SCHEMBL6874647

SCHEMBL6874647

C(=Cc1nc2ccc(-c3ncc[nH]3)cc2[nH]1)c1nc2ccc(-c3ncc[nH]3)cc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 2/20 0.44
TRPV1 Q8NER1 6/20 0.43
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
KDM4E B2RXH2 5/20 0.42
MAPT P10636 4/20 0.42
CACNA1B Q00975 1/20 0.42
APBA1 Q02410 1/20 0.42
MCL1 Q07820 1/20 0.42
ATM Q13315 1/20 0.42
MTOR P42345 1/20 0.42
ADK P55263 1/20 0.42
APP P05067 1/20 0.42
ALDH1A1 P00352 4/20 0.41
PKM P14618 3/20 0.41
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
GLA P06280 2/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL549264 0.94 SNCA (0.44) NISCHTRPV1MEN1KMT2AKDM4E
SCHEMBL6874639 0.90 NISCH (0.42) NISCHMEN1KMT2AKDM4EMAPT
SCHEMBL6874632 0.90 NISCH (0.42) NISCHMEN1KMT2AKDM4EMAPT
SCHEMBL548452 0.85 NISCH (0.38) NISCHTRPV1KDM4EALDH1A1
SCHEMBL549262 0.84 NISCH (0.41) NISCHMEN1KMT2AKDM4EMAPT
SCHEMBL549263 0.84 NISCH (0.41) NISCHMEN1KMT2AKDM4EMAPT
SCHEMBL548368 0.84 AAK1 (0.40) NISCHTRPV1MEN1KMT2AKDM4E
SCHEMBL5307580 0.80 RAB9A (0.60) NISCHMEN1KMT2AKDM4EMAPT
SCHEMBL548423 0.79 KMT2A (0.50) NISCHMEN1KMT2AKDM4EMAPT
SCHEMBL548480 0.79 F10 (0.46) NISCHMEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6815461-B1 ADMINISTERING BIS-BENZIMIDAZOLE COMPOUND; TREATING HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2004-11-09 US disclosed
EP-0739202-B1 USE OF BIS(AMIDINOBENZIMIDAZOLES) IN THE MANUFACTURE OF MEDICAMENT FOR INHIBITING RETROVIRAL INTEGRASE UNIV NORTH CAROLINA (US) 1998-12-16 EP disclosed